Warum Bitcoin als Wertspeicher in keinem diversifizierten Portfolio fehlen sollte. Jetzt lesen -w-
13.01.2014 14:03:35

Natus Medical Sees Q1, FY14 In Line With View - Quick Facts

(RTTNews) - Natus Medical Inc. (BABY) announced its financial guidance for the first quarter and full year 2014.

For the first quarter of 2014, the company expects to report revenue of $82 million to $86 million and non-GAAP earnings per share of $0.21 to $0.24, an increase of 33% to 53% over the first quarter of 2013 non-GAAP earnings per share of $0.15. Analysts polled by Thomson Reuters expect the company to report earnings of $0.24 per share and revenues of $85.65 million for the first-quarter. Analysts' estimates typically exclude special items.

For the full year 2014, the company expects to report revenue of $345 million to $350 million and non-GAAP earnings per share of $1.12 to $1.16. Street currently is looking for fiscal year 2014 earnings of $1.12 per share on annual revenues of $347.34 million.

The company also expects to report revenue of approximately $90.0 to $90.5 million for the fourth quarter of 2013. The company's previous revenue guidance for the fourth quarter was $87 million to $90 million. Four analysts estimated revenues of $89.12 million for the fourth-quarter.

The company's non-GAAP earnings per share guidance excludes charges for amortization expense associated with intangible assets from prior acquisitions, which the Company expects to be approximately $7.0 million and $1.7 million for the full year and first quarter 2014, respectively, and which the Company expects will reduce GAAP earnings per share by approximately $0.15 and $0.03 for the respective periods.

The Company's non-GAAP guidance includes the impact of expensing employee equity compensation.

The firm noted that it will release its 2013 fourth quarter financial results before the market opens on Wednesday, January 29, 2014.

Nachrichten zu Natus Medical Inc.mehr Nachrichten

Keine Nachrichten verfügbar.

Analysen zu Natus Medical Inc.mehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!